ArticlePharmaceutics2019

Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study.

Veera C S R Chittepu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.